BioAge Labs Files 8-K Report

Ticker: BIOA · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1709941

Bioage Labs, INC. 8-K Filing Summary
FieldDetail
CompanyBioage Labs, INC. (BIOA)
Form Type8-K
Filed DateJun 4, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

TL;DR

BioAge Labs filed an 8-K on 6/4/25 for 'Other Events' - need to check full doc for deets.

AI Summary

On June 4, 2025, BioAge Labs, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific details regarding transactions, material events, or financial figures were provided in the excerpt.

Why It Matters

This filing signals that BioAge Labs, Inc. has made a disclosure to the SEC, which could pertain to significant corporate events. Investors should review the full filing for details.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate immediate risk.

Key Players & Entities

FAQ

What specific 'Other Events' are disclosed in this 8-K filing by BioAge Labs, Inc.?

The provided excerpt of the 8-K filing does not specify the nature of the 'Other Events'.

When was this 8-K report filed by BioAge Labs, Inc.?

This 8-K report was filed on June 4, 2025.

What is the Commission File Number for BioAge Labs, Inc.?

The Commission File Number for BioAge Labs, Inc. is 001-42279.

What is the principal executive office address for BioAge Labs, Inc.?

The principal executive offices of BioAge Labs, Inc. are located at 5885 Hollis Street Suite 370, Emeryville, California 94608.

What is the IRS Employer Identification Number for BioAge Labs, Inc.?

The IRS Employer Identification Number for BioAge Labs, Inc. is 47-4721157.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding BioAge Labs, Inc. (BIOA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing